Article

Exogenous Nanog alleviates but is insufficient to reverse embryonic stem cells differentiation induced by PI3K signaling inhibition.

State Key Laboratory of Experimental Hematology, Institute of Hematology, National Research Center for Stem Cell Engineering and Technology, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
Journal of Cellular Biochemistry (impact factor: 2.87). 03/2009; 106(6):1041-7. DOI:10.1002/jcb.22082 pp.1041-7
Source: PubMed

ABSTRACT PI3K signaling pathway plays a significant role in embryonic stem cells (ES cells) self-renewal. Overexpression of Nanog maintains mouse ES cells pluripotency independent of leukemia inhibitory factor (LIF). However, little is known about the effect of PI3K signaling pathway on ES cells with Nanog overexpression. Our experiments aimed to explore the relationship between PI3K signaling pathway and Nanog expression in ES cells. We observed the effect of LY294002, a specific inhibitor of PI3K pathway, on wild-type J1 cells and Nanog overexpressing (Ex-Nanog) J1 cells in the presence or absence of LIF. With LY294002 treatment, both of them lost their ES features even in the presence of LIF. But the differentiation induced by LY294002 on Ex-Nanog J1 cells was slighter lower than that on wild-type J1 cells. These results indicate that inhibition of PI3K pathway induces mouse ES cells differentiation. Exogenous Nanog sustains mouse ES cells pluripotency independent of LIF, and alleviates the differentiation induced by LY294002. But it is insufficient to totally reverse the differentiation.

0 0
 · 
0 Bookmarks
 · 
25 Views

Keywords

differentiation induced
 
ES cells
 
ES features
 
Ex-Nanog
 
Ex-Nanog J1 cells
 
Exogenous Nanog sustains mouse ES cells pluripotency independent
 
inhibition
 
leukemia inhibitory factor
 
mouse ES cells pluripotency independent
 
Nanog
 
Nanog expression
 
Nanog overexpressing
 
Nanog overexpression
 
Overexpression
 
PI3K pathway
 
PI3K pathway induces mouse ES cells differentiation
 
PI3K signaling pathway
 
significant role
 
specific inhibitor
 
wild-type J1 cells